EVOTEQ announced that it will showcase its ‘Track and Trace’ technology SmartTrack at DUPHAT 2021 from April 5 to 7 at Dubai World Trade Centre at stand number 4C10. The company will demonstrate how SmartTrack can be applied in healthcare given that healthcare serialization is a major challenge. During its participation in the global event for the pharmaceutical industry, the company will highlight how the solution uses serialization and advanced cloud platforms to track and trace supply chain elements to enhance efficiency, reliability, and authenticity of the healthcare industry.

The current times have once again highlighted the need for a seamlessly functioning healthcare system that addresses the needs of hospitals, pharmacies, and consumers to ultimately enhance the quality of life. Against this backdrop, SmartTrack has been designed to ensure that all pharmaceutical drugs, blood products, and medical devices, entering the country’s borders are well verified, authenticated, and safe for consumption. By increasing visibility and trust across different industries including healthcare and pharma, it enables tracking of the entire product journeys, in addition to offering end to end monitoring and analysis.

Jihad Tayara, CEO of EVOTEQ, said: “The importance of global supply chain came to the forefront once again during COVID - especially the lack of visibility across the healthcare industry’s supply chain. On top of that, the risk of counterfeit drugs entering the supply chain is a growing problem around the world. EVOTEQ’s SmartTrack – a track-and-trace cloud-based platform addresses this challenge by following the flow of drugs and other healthcare items’ information right from the point-of-manufacture to the point-of-sale and the end-users. This streamlines the supply chain process to enhance operational efficiency and gives customers real-time information of the source of their products or services, thereby ensuring the safe production and distribution of products and services in a timely manner.”

Powered by blockchain, SmartTrack can serve as a crucial link in product safety, validation and counterfeit prevention by uniting all stakeholders against counterfeits, contamination, shortages and other vulnerabilities. Therefore, empowering consumers with the ability to validate and verify products across all critical points of the global supply chain. SmartTrack’s applications span a wide range of industries, however at DUPHAT, EVOTEQ will be focusing on its application in the pharmaceutical industry alone.

-Ends-

About EVOTEQ:

EVOTEQ is a UAE based digital transformation catalyst that creates digitally empowered smarter societies by providing innovative and transformative solutions and platforms to governments and large enterprises across the region. The company enables its customers to improve performance, increase efficiency, and make faster and better decisions, thereby helping them to meaningfully create a positive impact on people’s lives. Working collaboratively with enterprises seeking digital transformation, EVOTEQ’s team of experts offer consulting and advisory on comprehensive strategies as well as design high-tech, advanced solutions ranging from business applications, data analytics, smart technology, AI, and blockchain.

For further information, please contact:
Orient Planet Group (OPG)
Tel:  +971 4 4562888
Email: media@orientplanet.com
Website: www.orientplanet.com  

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.